Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|September 13, 2006
Peptide deformylase inhibitors as potent antimycobacterial agentsJeanette W P Teo, Pamela Thayalan, David Beer, et al.Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.Journal of Medicinal Chemistry|August 24, 2019
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-N1)-Methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-Flipping MechanismWenhe Zhong, Kalyan Kumar Pasunooti, Seetharamsing Balamkundu, et al.Mbio|May 7, 2015
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteriaWilfried Moreira, Grace J Y Ngan, Jian Liang Low, et al.Journal of Medicinal Chemistry|October 5, 2013
Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agentsRavinder Reddy Kondreddi, Jan Jiricek, Srinivasa P S Rao, et al.European Journal of Medicinal Chemistry|August 13, 2016
Amphiphilic xanthones as a potent chemical entity of anti-mycobacterial agents with membrane-targeting propertiesJun-Jie Koh, Hanxun Zou, Devika Mukherjee, et al.Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.Journal of Medicinal Chemistry|May 26, 2023
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in MycobacteriaSatish R Malwal, Ben Mazurek, Jihee Ko, et al.Ebiomedicine|January 1, 2026
Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteriaMinh-Vu H Nguyen, Michel Plattner, Deepshikha Verma, et al.Antimicrobial Agents and Chemotherapy|January 31, 2022
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case StudyFirat Kaya, Jacqueline P Ernest, Katherine LoMauro, et al.Pageof 17